Editorial
The 2001 Guinness Book of World Records list periodontal diseases as the most common disease of humankind. Gingivitis and periodontitis that are also chronic noncommunicable diseases are the most common type of periodontal diseases. Both are plaque-induced inflammatory conditions with multifactorial destructive nature. Initiation of the diseases requires the adherence of the pathogenic bacteria to tooth surfaces and triggering the inflammatory response in periodontal tissues. Hence, initial periodontal treatment of the diseases consists of mechanical debridement to remove bacterial plaque and calculus from the root surfaces. Maintenance of oral hygiene, scaling and root planing and periodontal surgeries if necessary provide expected results in most cases since the biofilm is disrupted mechanically. [1] However, when pathogenic bacteria are residing within periodontal tissues or in deep pockets or root furcation defects or root concavities or grooves, to access these sides for mechanical debridement would be limited. [2] Systemic antimicrobial therapy in periodontal treatment may provide benefits as an adjunct to mechanical periodontal debridement. [3] Especially, aggressive periodontitis patients have more benefits from nonsurgical therapy together with systemic antibiotics comparing to nonsurgical treatment alone. [4] [5] [6] Systemic antibiotics, including amoxicillin (with or without clavulanic acid), azithromycin, clindamycin, doxycycline, metronidazole, spiramycin, moxifloxacin, tetracycline, and combination of these antibiotics have been investigated in clinical studies, and there are a number of reviews and meta-analyses on this subject. [7, 8] Systemic administration of the antimicrobial agent may provide some advantages such as wide distribution all through the body which may increase the therapeutic potential of the agent, on the other hand, systemic administration requires good patient compliance and may cause of systemic side effects.
Periodontitis patients may not have an identical microbial profile and the antibiotic susceptibility/resistance of periodontopathogens for unique antibiotic regimes, so it seems it is not possible to provide a consensus in the administration of antibiotics in periodontitis patients. [9] Moreover, there is no consensus on timing of the antibiotic use and dosages, length of the antibiotic therapy, and the appropriate antibiotic agents or combinations due to the nature of the biofilm in the periodontal therapy. Usually, when there is no standard treatment protocols or consensus reports, antibiotics are often over-prescribed. [10] The World Health Organization (WHO) has reported that "antibiotic resistance is rising dangerously high levels in all parts of the world and a growing list of infections are becoming harder, and sometimes impossible, to treat as antibiotics become less effective."
The role of health professions in the action plan for the prevention and control of the antibiotic use by the WHO is described in detail as follows:
"To prevent and control the spread of antibiotic resistance, health professionals can, [10] • Prevent infections by ensuring your hands, instruments, and environment are clean • Only prescribe and dispense antibiotics when they are needed, according to the current guidelines • Report antibiotic-resistant infections to surveillance teams • Talk to your patients about how to take antibiotics correctly, antibiotic resistance, and the dangers of misuse • Talk to your patients about preventing infections (for example, vaccination, hand washing, safer sex, and covering nose and mouth when sneezing).
"A global action plan on antimicrobial resistance, including antibiotic resistance ", was endorsed at the World Health Assembly in May 2015. The global action plan aims to ensure the prevention and treatment of infectious diseases with safe and effective medicines.
The "Global action plan on antimicrobial resistance" has five strategic objectives: [10] • To improve awareness and understanding of antimicrobial resistance • To strengthen surveillance and research • To reduce the incidence of infection • To optimize the use of antimicrobial medicines • To ensure sustainable investment in countering antimicrobial resistance.
Systemic Antibiotics in the Treatment of Periodontitis
A political declaration endorsed by Heads of State at the United Nations General Assembly in New York in September 2016 signaled the world's commitment to taking a broad, coordinated approach to address the root causes of antimicrobial resistance across multiple sectors, especially human health, animal health, and agriculture. The WHO is supporting member states to develop national action plans on antimicrobial resistance, based on the global action plan."
We are expected to act responsibly as health providers.
